Klinik für Thoraxchirurgie

Beruflicher Werdegang

Akademischer Werdegang

Qualifikation

Auszeichnungen und Drittmittel

Beirat/Herausgeber von Zeitschriften

• Editorial Board Member, Zentralblatt für Chirurgie
• Editorial Board Member, Scientific Reports
• Editorial Board Member, Innovative Surgical Sciences

Mitgliedschaften

• Deutsche Krebsgesellschaft
• Arbeitsgemeinschaft Onkologische Thoraxchirurgie (AOT)
• Deutsche Gesellschaft für Thoraxchirurgie
• Deutsche Gesellschaft für Chirurgie
• International Association for the Study of Lung Cancer

Publikationen

Originalarbeiten als Erst- oder Letztautor

• Le, U. T., Titze, L., Hundeshagen, P., Passlick, B., & Schmid, S. (2023). Robotic diaphragm plication: functional and surgical outcomes of a single-center experience. Surgical Endoscopy, 37(6), 4795–4802. https://doi.org/10.1007/s00464-023-09942-7
• Le, U. T., Passlick, B., & Schmid, S. (2023). Surgery for thoracic oligoprogression in metastatic renal cell cancer in the era of new systemic therapies. Journal of Thoracic Disease, 15(3), 1133–1141. https://doi.org/10.21037/JTD-22-1120
• Schmid S, Minnella EM, Pilon Y, Rokah M, Rayes R, Najmeh S, Cools-Lartigue J, Ferri L, Mulder D, Sirois C, Owen S, Shieh B, Ofiara L, Wong A, Sud S, Baldini G, Carli F, Spicer J: Neoadjuvant prehabilitation therapy for locally advanced non-small-cell lung cancer: Optimizing outcomes throughout the trajectory of care. Clin Lung Cancer, 2022. DOI: 10.1016/j.cllc.2022.05.004
• Schmid S, Kaafarani M, Baldini G, Amir A, Costescu F, Shafiepour D, Cools-Lartigue J, Najmeh S, Sirois C, Ferri L, Mulder D and Spicer J: Implication of a novel postoperative recovery protocol to increase day 1 discharge rate after anatomic lung resection. J Thorac Dis 13: 6399–6408, 2021. DOI: 10.21037/JTD-21-965.
• Hassan M, Le U-T, Grapatsas K, Passlick B and Schmid S: [Surgery for Thoracic Malignancies during the COVID-19 Pandemic: a Case-control Study Investigating the Risk for Postoperative Complications]. Zentralbl Chir 146: 579–585, 2021. PMID: 34872113. DOI: 10.1055/A-1678-7533
• Hassan M, Graeter T, Dietrich I, Kemna LJ, Passlick B and Schmid S: Surgical Morbidity and Lung Function Changes After Laser–Assisted Pulmonary Metastasectomy:
  A Prospective Bicentric Study. Front Surg 8, 2021.https://doi.org/10.3389/fsurg.2021.646269.
• Schmid S, Schibilsky D, Kalbhenn J, Hassan M, Loop T, Passlick B, Beyersdorf F and Czerny M: Reconstruction of the Mediastinum and Tracheopexy for Tracheomalacia in Straight-Back-Syndrome. Ann Thorac Surg, 2021. https://doi.org/10.1016/j.athoracsur.2020.11.045.
• Le UT, Bronsert P, Picardo F, Riethdorf S, Haager B, Rylski B, Czerny M, Pantel K, Wiesemann S, Passlick B, Kaifi JT and Schmid S: Intraoperative detection of circulating tumor cells in pulmonary venous blood during metastasectomy for colorectal lung metastases. Sci Rep 8: 8751, 2018. https://doi.org/10.1038/s41598-018-26410-8.
• Haager B, Poguntke I, Passlick B, Wiesemann S and Schmid S: Prognostic value of lymph node ratio after induction therapy in stage IIIA/N2 non-small-cell lung cancer: a monocentric clinical study. J Thorac Dis 10(6):3225-3231, 2018. https://doi.org/10.21037/jtd.2018.05.138.
• Schmid S, Le UT, Zeisel C, Haager B and Passlick B: Pulmonary metastasectomy in sarcoma—experiences with laser-assisted resection. J Thorac Dis 10: 314–320, 2018. https://doi.org/10.21037/jtd.2017.12.06.
• Schmid S, Le UT, Haager B, Mayer O, Dietrich I, Elze M, Kemna LJ, Zissel G and Passlick B: Local Concentrations of CC-Chemokine-Ligand 18 Correlate with Tumor Size in Non-small Cell Lung Cancer and Are Elevated in Lymph Node-positive Disease. Anticancer Res 36: 4667–71, 2016. https://doi.org/10.21873/anticanres.11018.
• Schmid S, Csanadi A, Kozhuharov N, Tchudjin M, Kayser C, Rawluk J, Passlick B, Prasse A and Kayser G: CC-Chemokine Ligand 18 is an independent prognostic marker in lymph node positive non-small cell lung cancer. Anticancer Res 38: 3913–3918, 2018. https://doi.org/10.21873/anticanres.12676.
• Schmid S, Kübler M, Ayata KC, Lazar Z, Haager B, Hoßfeld M, Meyer A, Cicko S, Elze M, Wiesemann S, Zissel G, Passlick B and Idzko M: Altered purinergic signaling in the tumor associated immunologic microenvironment in metastasized non-small-cell lung cancer. Lung Cancer 90: 516–521, 2015. https://doi.org/10.1016/j.lungcan.2015.10.005.
• Schmid S, Aicher M, Csanadi A, Passlick B and Kaifi JT: Significance of the resection margin in bronchopulmonary carcinoids. J Surg Res 201: 53–58, 2016. https://doi.org/10.1016/j.jss.2015.09.036.
• Schmid S, Csanadi A, Kaifi JT, Kübler M, Haager B, Kayser G, Passlick B and Wiesemann S: Prognostic factors in solitary fibrous tumors of the pleura. J Surg Res 195: 580–7, 2015. https://doi.org/10.1016/j.jss.2015.01.049.
• Schmid S, Koepke J, Dresel M, Hattesohl A, Frenzel E, Perez J, Lomas DA, Miranda E, Greulich T, Noeske S, Wencker M, Teschler H, Vogelmeier C, Janciauskiene S and Koczulla AR: The effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency. Int J COPD 7: 687–696, 2012. https://doi.org/10.2147/COPD.S34560.

Originalarbeiten als Koautor

• Hassan, M., Zimmermann, J., Schmid, S., Passlick, B., Kovacs, J., Hatz, R., Winter, H., Klotz, L., Eichhorn, M., Markowiak, T., Müller, K., Huppertz, G., Koller, M., Hofmann, H.S., & Ried, M. (2023). Outcome after cytoreductive surgery combined with hyperthermic intrathoracic chemotherapy in patients with secondary pleural metastases. Frontiers in Oncology,13:1259779. https://doi.org/10.3389/fonc.2023.1259779
• Ried, M., Hassan, M., Passlick, B., Schmid, S., Markowiak, T., Müller, K., Huppertz, G., Koller, M., Winter, H., Klotz, L. V, Hatz, R., Kovács, J., Zimmermann, J., Hofmann, H.-S., & Eichhorn, M. E. (2023). Surgical cytoreduction and hyperthermic intrathoracic chemotherapy for thymic tumours with pleural spread is effective on survival: results from the multicentre German hyperthermic intrathoracic chemotherapy study. Interdisciplinary Cardiovascular and Thoracic Surgery, 36(6). https://doi.org/10.1093/ICVTS/IVAD032
• de Rooij, B. H., van den Hurk, C., Smaardijk, V., Fernandez-Ortega, P., Navarro-Martin, A., Barberio, L., Guckenberger, M., Schmid, S., Walraven, I., Vallow, S., Kotsi, C., Preusser, M., Mosor, E., Klok, J. M., Becker, A., Milani, A., Ninov, L., & van de Poll-Franse, L. v. (2022). Development of an updated, standardized, patient-centered outcome set for lung cancer. Lung Cancer (Amsterdam, Netherlands), 173, 5–13. https://doi.org/10.1016/J.LUNGCAN.2022.08.021
• Grapatsas, K., Hassan, M., Semmelmann, A., Ehle, B., Passlick, B., Schmid, S., & Le, U.-T. (2022). Should cardiovascular comorbidities be a contraindication for pulmonary metastasectomy? Journal of Thoracic Disease, 14(11), 0–0. https://doi.org/10.21037/JTD-22-409
• Ried M, Kovács J, Markowiak T, Müller K, Huppertz G, Koller M, Winter H, Klotz L V., Hatz R, Zimmermann J, Passlick B, Schmid S, Hassan M, Eichhorn ME and Hofmann HS: Hyperthermic intrathoracic chemotherapy (Hitoc) after cytoreductive surgery for pleural malignancies—a retrospective, multicentre study. Cancers (Basel) 13, 2021. PMID: 34572806. DOI: 10.3390/cancers13184580.
• Schmid S as part of the COVIDSurg Collaborative: Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score. Br J Surg 19: 1–19, 2021. PMID: 34227657. DOI: 10.1093/bjs/znab183.
• Schmid S as part of the CovidSurg Collaborative: Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. Lancet Oncol 0, 2021. PMID: 34624250. DOI: 10.1016/S1470-2045(21)00493-9.
• Seitlinger J, Wollbrett C, Mazzella A, Schmid S, Guerrera F, Nkomo DB, Hassan M, Brindel A, Ruuth Praz J, Schmitt P, Clément-Duchêne C, Douiri N, Reeb J, Prisciandaro E, Siat J, Spaggiari L, Ruffini E, Filosso P, Ferri L, Santelmo N, Spicer J and Renaud S: Safety and feasibility of thoracic malignancy surgery during the COVID-19 pandemic. Ann Thorac Surg, 2020. https://doi.org/10.1016/j.athoracsur.2020.12.001.
• Ferreira V, Minnella EM, Awasthi R, Gamsa A, Ferri L, Mulder D, Sirois C, Spicer J, Schmid S and Carli F: Multimodal Prehabilitation for Lung Cancer Surgery: A Randomized Controlled Trial. Ann Thorac Surg, 2020. https://doi.org/10.1016/j.athoracsur.2020.11.022.
• Palade E, Günter J, Gomez JMM, Wellner UF, Schmid S, Wiesemann S and Passlick B: Morbidity, mortality and long-term outcome of lung cancer resections performed in palliative intent. J Thorac Dis 11: 4308–4318, 2019. https://doi.org/10.21037/jtd.2019.09.61
• Moneke I, Funcke F, Schmid S, Osei-Agyemang T and Passlick B: Pulmonary laser-assisted metastasectomy is associated with prolonged survival in patients with colorectal cancer. J Thorac Dis 11: 3241–3249, 2019. https://doi.org/10.21037/jtd.2019.08.73.
• Grapatsas K, Schmid S, Haager B, Loop T, Passlick B: Short veno-venous extracorporeal membrane oxygenation assisted segmentectomy for second primary lung tumor in a patient with insufficient respiratory function for one lung ventilation. Respir Med Case Rep 24: 176-178, 2018. https://doi.org/10.1016/j.rmcr.2018.05.027.
• Mecklenburg I, Sienel W, Schmid S, Passlick B and Kufer P: A Threshold of Systemic MAGE-A Gene Expression Predicting Survival in Resected Non–Small Cell Lung Cancer. Clin Cancer Res 23: 1213–1219, 2017. https://doi.org/10.1158/1078-0432.CCR-16-0557.
• Hüttmann E-M, Greulich T, Koepke J, Nell C, Hattesohl A, Schmid S, Noeske S, Herr C, John G, Jörres RA, Müller B, Vogelmeier C and Koczulla AR: Correction: Comparison of Two Devices and Two Breathing Patterns for Exhaled Breath Condensate Sampling. PLoS One 11: e0152620, 2016. https://doi.org/10.1371/journal.pone.0152620.
• Haager B, Kayser G, Schmid S, Passlick B and Wiesemann S: Intrapulmonary Castleman’s disease pretending to be a lung cancer — Work up of an intrapulmonary tumour. Ann Thorac Cardiovasc Surg 22: 258–260, 2016. https://doi.org/10.5761/atcs.cr.15-00216.
• Koepke J, Dresel M, Schmid S, Greulich T, Beutel B, Schmeck B, Vogelmeier CF, Janciauskiene S and Koczulla AR: Therapy with plasma purified alpha1-antitrypsin (Prolastin®) induces time-dependent changes in plasma levels of MMP-9 and MPO. PLoS One 10: e0117497, 2015. https://doi.org/10.1371/journal.pone.0117497.
• Bach JP, Gold M, Mengel D, Hattesohl A, Lubbe D, Schmid S, Tackenberg B, Rieke J, Maddula S, Baumbach JI, Nell C, Boeselt T, Michelis J, Alferink J, Heneka M, Oertel W, Jessen F, Janciauskiene S, Vogelmeier C, Dodel R, Koczulla AR and Blum D: Measuring compounds in exhaled air to detect Alzheimer’s disease and Parkinson’s disease. PLoS One 10: e0132227, 2015. https://doi.org/10.1371/journal.pone.0132227.
• Greulich T, Hattesohl A, Grabisch A, Koepke J, Schmid S, Noeske S, Nell C, Wencker M, Jörres R a., Vogelmeier CF, Köhler U and Koczulla AR: Detection of obstructive sleep apnoea by an electronic nose. Eur Respir J 42: 145–155, 2013. https://doi.org/10.1183/09031936.00091712.
• Koczulla AR, Noeske S, Herr C, Koepke J, Jörres RA, Nell C, Schmid S, Vogelmeier C and Bals R: Alpha-1 antitrypsin is elevated in exhaled breath condensate and serum in exacerbated COPD patients. Respir Med 106: 120–126, 2012. https://doi.org/10.1016/j.rmed.2011.06.015.
• Hattesohl ADM, Jörres RA, Dressel H, Schmid S, Vogelmeier C, Greulich T, Noeske S, Bals R and Koczulla AR: Discrimination between COPD patients with and without alpha 1-antitrypsin deficiency using an electronic nose. Respirology 16: 1258–1264, 2011. https://doi.org/10.1111/j.1440-1843.2011.02047.x.
• Koczulla R, Hattesohl A, Schmid S, Bödeker B, Maddula S and Baumbach JI: MCC/IMS as potential noninvasive technique in the diagnosis of patients with COPD with and without alpha 1-antitrypsin deficiency. Int J Ion Mobil Spectrom 14: 177–185, 2011. https://doi.org/10.1007/s12127-011-0070-0.
• Koczulla AR, Noeske S, Herr C, Dette F, Pinkenburg O, Schmid S, Jörres RA, Vogelmeier C and Bals R: Ambient temperature impacts on pH of exhaled breath condensate. Respirology 15: 155–159, 2010. https://doi.org/10.1111/j.1440-1843.2009.01664.x.

Übersichtsartikel

• Schmid S: Highly Variable Clinical Manifestations of Straight-Back-Syndrome in the Young and the Elderly. Ann Thorac Surg, 2021. https://doi.org/10.1016/j.athoracsur.2021.05.069.
• Ried M, Schmid S, Fischer S, Hohenberger P, Neudecker J, Spillner J, Hofmann H-S and Walles T: Nachwuchsakademie der DGT: Förderung von Forschungsnachwuchs in der Thoraxchirurgie. Zentralblatt für Chir - Zeitschrift für Allg Visz Thorax- und Gefäßchirurgie 146: 318–318, 2021. https://doi.org/10.1055/s-0037-1599669.
• Haager B, Passlick B und Schmid S: Postoperative Blutung nach thoraxchirurgischen Eingriffen. Zentralblatt fur Chir - Zeitschrift fur Allg Visz und Gefasschirurgie 144: S20–S23, 2019. https://doi.org/10.1055/a-0808-4970
• Schmid S, Passlick B, Stuschke M and Griesinger F: Oligometastatische Erkrankung des nichtkleinzelligen Lungenkarzinoms. Der Onkologe - Dezember 2018
• Schmid S und Passlick B: Die Bedeutung der Chirurgie beim oligometastatischen und oligoprogressiven nicht kleinzelligen Lungenkarzinom. Zentralblatt für Chir 142: S38–S43, 2017. https://doi.org/10.1055/s-0043-115641.
• Passlick B und Schmid S: Chirurgie des lokal fortgeschrittenen Lungenkarzinoms. Passion Chirurgie. 2-2016.
• Schmid S und Passlick B. (2015) Was gibt es Neues in der lokalen Behandlung von Pleuratumoren? Was gibt es neues in der Chirurgie? Jahresband 2015.
• Kaifi JT, Schmid S und Passlick B: Typische und atypische Karzinoide der Lunge: chirurgische Behandlungsstrategie. Zentralblatt für Chir 141: 105–120, 2016. https://doi.org/10.1055/s-0041-111661.
• Wiesemann S, Schmid S, Haager B und Passlick B: Mediastinitis: Klinik und Behandlungsoptionen. Zentralblatt für Chir - Zeitschrift für Allg Visz Thorax- und Gefäßchirurgie 140: S8–S15, 2015. https://doi.org/10.1055/s-0035-1557779.
• Koczulla AR, Greulich T, Schmid S, Kenn K, Heinzelmann I und Vogelmeier C: COPD. Der Pneumol 8: 359–371, 2011. https://doi.org/10.1007/s10405-011-0515-5.